| 1 |
Andrew Robert Pacey |
Limflow Gmbh |
5 |
| 1 |
Niall Andrew Anderson |
Glaxosmithkline Intellectual Property Development Limited |
5 |
| 3 |
John Martin Pritchard |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| 3 |
Stephen John Atkinson |
Glaxosmithkline Intellectual Property (No. 4) Limited |
4 |
| #5 |
Alexander G. Preston |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
Alan Peter Lewis |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #5 |
Matthew Lindon |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
Ian David Wall |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
Jonathan Thomas Seal |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
James Michael Woolven |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
Emmanuel Hubert Demont |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #5 |
Matthew Howard James Campbell-Crawford |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #5 |
John Liddle |
Glaxo Group Limited |
3 |
| #5 |
Ashley Paul Hancock |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #5 |
Ann Louise Walker |
Glaxo Group Limited |
3 |
| #5 |
Lee Andrew Harrison |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #17 |
Keith Biggadike |
Glaxo Group Limited |
2 |
| #17 |
Diane Mary Coe |
Glaxo Group Limited |
2 |
| #17 |
Daniel Terence Tape |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #17 |
Sandra May Bernadette HOLMES |
Creo Medical Limited |
2 |
| #17 |
Aurelie Cecile Champigny |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #17 |
John David Harling |
Smithkline Beeacham P.L.C. |
2 |
| #17 |
Paul Andrew Hamblin |
Glaxo Group Limited |
2 |
| #17 |
Conrad VINK |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #17 |
Stephen Sweeney |
Astrium Gmbh |
2 |
| #17 |
Seble Lemma |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #17 |
Vipulkumar Kantibhai Patel |
Smithkline Beecham Limited |
2 |
| #17 |
Panayiotis Alexandrou Procopiou |
Glaxo Group Limited |
2 |
| #17 |
Ian Edward David Smith |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #17 |
Julie Nicole Hamblin |
Glaxo Group Limited |
2 |
| #31 |
Armelle Le Gall |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Giuseppe Alvaro |
Autifony Therapeutics Limited |
1 |
| #31 |
Agostino Marasco |
Autifony Therapeutics Limited |
1 |
| #31 |
Celeste PALLANT |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Sabine JOHNSON |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Suzanne Elaine Keeling |
Glaxo Group Limited |
1 |
| #31 |
Susannah Karen Ford |
Glaxo Group Limited |
1 |
| #31 |
Edward Paul Cannons |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Hawa Diallo |
Glaxo Group Limited |
1 |
| #31 |
John David Hayler |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Michael Robert Webb |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Robert John Sheppard |
Glaxo Group Limited |
1 |
| #31 |
Clement Douault |
Glaxo Group Limited |
1 |
| #31 |
Alan Geoffrey Ironmonger |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Robert David Willacy |
Glaxo Group Limited |
1 |
| #31 |
Peter Finney |
Avaya |
1 |
| #31 |
Ian Baxter Campbell |
Glaxo Group Limited |
1 |
| #31 |
Brendan John Fallon |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #31 |
Deborah Needham |
Glaxo Group Limited |
1 |
| #31 |
Steven Leslie Sollis |
Glaxo Group Limited |
1 |